<DOC>
	<DOCNO>NCT02851953</DOCNO>
	<brief_summary>The purpose present clinical investigation collect data regard safety effectiveness Aqueduct 100 device . The effectiveness Aqueduct 100 determine evaluate ability reach desire cervical dilation , time frame require reach desire cervical dilation .</brief_summary>
	<brief_title>Effectiveness Safety Evaluation Aqueduct -100 Device</brief_title>
	<detailed_description />
	<mesh_term>Dilatation , Pathologic</mesh_term>
	<criteria>1 . Subjects , female , 18 year age old . 2 . Subjects undergo process require dilation ( intrauterine procedure ) . 3 . Subjects understanding nature study willing sign inform consent form . 1 . Subjects young 18 year age . 2 . Subject follow infectious disease : HIV , HBV , HCV , Syphilis . 3 . Subject treat cervix dilate agent within 2 month screen . 4 . Known contraindication hypersensitivity component investigational product . 5 . The patient condition concurrent severe and/or uncontrolled medical disease could compromise participation , compliance , and/or completion study procedure . 6 . Subjects undergo abortion &lt; 7 &gt; 9 week pregnancy . 7 . Subjects unwilling sign inform consent form .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>cervix , cervical dilation , balloon catheter</keyword>
</DOC>